GPT and anemia (phenotype): Grade ≥3 AEs that were causally related to any treatment occurred in seven (43.8%) patients and included decreased neutrophil count (25.0%), anemia (6.3%), abnormal hepatic function (6.3%), myositis (6.3%), increased alanine aminotransferase (6.3%), increased amylase (6.3%), and increased aspartate aminotransferase (6.3%).